Southeast Asia Information Port News (www.dnyxxg.com) Ying Jiangxian, an interventional neurology expert from the First People's Hospital of Taizhou City, Zhejiang Province, who recently completed his service period in Xinjiang, has returned to the Alar Hospital of Zhejiang University's Sir Run Run Shaw Hospital to conduct flexible support work in Xinjiang.
Through integrated assistance including outpatient consultations, surgical guidance, and teaching, he comprehensively helps the recipient hospital upgrade its interventional neurology subspecialty, enabling local residents to enjoy high-level neurointerventional diagnosis and treatment services.
As an associate chief physician, Ying Jiangxian has long been engaged in interventional treatment of cerebrovascular diseases such as intracranial artery stenosis, carotid artery stenosis, and thrombectomy for acute ischemic stroke, accumulating rich experience in clinical practice and discipline development. During this flexible support period in Xinjiang, he closely integrated with the key development directions of the neurology department of the recipient hospital and formulated a scientific and compact work plan.
During his outpatient consultations, Ying Jiangxian patiently sees patients with various cerebrovascular diseases, dizziness, headaches, sequelae of cerebral infarction, and high-risk screening patients. He meticulously inquires about each patient's medical history, analyzes imaging data, and develops individualized integrated plans for medication, interventional intervention, and rehabilitation follow-up. Meanwhile, he actively disseminated knowledge about stroke prevention, chronic disease management, and postoperative care to the public, effectively reducing the burden on patients seeking medical treatment in other locations.
For a highly complex interventional surgery, Ying Jiangxian conducted a detailed preoperative assessment and provided guidance on key intraoperative techniques. He demonstrated the entire process, from operational procedures and risk assessment to emergency response, effectively enhancing the confidence and competence of the neurointerventional team at the recipient hospital in handling complex cases.
Drawing upon his extensive clinical experience, Ying Jiangxian explained the exploration of cerebrovascular interventional therapy via the radial artery approach in a clear and concise manner. He shared his experience in head and neck vascular balloon angioplasty and stent implantation, delivering an academic lecture to the department's medical staff that combined theoretical depth with practical guidance.
He was also invited to participate in the hospital-sponsored "Zhejiang University Sir Run Run Shaw Hospital Alar Hospital Southern Xinjiang Neurointerventional Silk Road Summit: Oasis Forum (Second Session)" continuing education training course, where he delivered a special report on "Complex Tortuous Carotid Artery Stenting Strategies." He also engaged in interactive discussions with colleagues from various regions, answering questions about surgical difficulties and diagnostic challenges.
After returning to Zhejiang from his aid work in Xinjiang, Ying Jiangxian remained concerned about the development of the hospital in the recipient area. After careful consideration, he resolutely chose to return to Xinjiang again through a flexible aid program. "Alar is my second hometown. Stepping onto this land again fills me with excitement," he said.
This flexible aid program is not only a vivid example of Zhejiang-Alar medical cooperation, but also an important measure for Zhejiang University Sir Run Run Shaw Hospital Alar Hospital to strengthen its disciplines by "bringing in" experts. Through the deployment of experts, patients in the border region can enjoy high-level medical services "at their doorstep," and the department has achieved significant improvements in the diagnosis and treatment of complex cerebrovascular diseases, standardized surgical procedures, and multidisciplinary collaboration, injecting strong momentum into talent development and subspecialty development. (End)
